- The Foundation For Peripheral Neuropathy - https://www.foundationforpn.org -

Research Study for Painful Diabetic Peripheral Neuropathy

Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple Dose Study to Assess the Efficacy and Safety of NYX-2925 in Subjects with Neuropathic Pain Associated with Diabetic Peripheral Neuropathy.

Aptinyx Inc. [1] is conducting a research study evaluating multiple doses of its investigational drug NYX-2925 versus placebo in treating the neuropathic pain associated with diabetic peripheral neuropathy [2]. Enrollment into this study will run from July 2017 through October 2018. Subjects will participate in the trial from six to nine weeks.

NYX-2925 is an investigational drug that is being studied for treatment of nerve pain associated with diabetic peripheral neuropathy and for fibromyalgia. Evaluations include questions about your pain level, medications, and your overall well-being.  Qualified patients will receive all investigational study drugs at no cost, study-related care from the study doctor at no cost, and possibly compensation for time and travel.

You may be qualified to join this research study if you are:

You may not participate in this research study if you have:

Other requirements:

The research study is being conducted at the following locations:

To find out more information about this research study or to find a study location near you, please visit mydpnstudies.com [3] or call Acurian (agent for Aptinyx Inc.) at 855-452-8072.

This research study is also posted on the clinicaltrials.gov site. Click here to read more. [4]

To find out more about other clinical trials being offered to peripheral neuropathy patients, please go to theFoundation for Peripheral Neuropathy’s Clinical Trials website [5].